SCHEME 2. Synthesis of D-erythro-Sphingosine (1)
modest isolated yield in our hands. The analytical and spectro-
scopic data of both the synthetic 1 and its triacetate derivative
1021 were identical to those reported.6,8,22
In conclusion, these studies provide a practical preparative
route to D-erythro-sphingosine (1) from the low cost phytos-
phingosine 2 in high overall yield (ca 60%). An important
feature of this synthesis is the selective transformation of the
3,4-vicinal diol of phytosphingosine into the characteristic E-
allylic alcohol of sphingosine via a cyclic sulfate. The treatment
of cyclic sulfate 6 with Bu4NI/ DBU led to the exclusive for-
mation of trans olefin in high yield. This transformation is com-
plementary to the eliminative epoxide opening. Further studies
will be forthcoming which will elucidate the scope and limi-
tations of the elimination reaction of cyclic sulfate in an acyclic
system.
Pleased with this result, we studied the direct one-pot ring
opening/ dehydrohalogenation sequence. After the nucleophilic
ring opening reaction in THF was completed as judged by TLC
analysis, DBU was added and the reaction temperature was
raised to reflux. This treatment followed by acidic hydrolysis
successfully furnished the desired E-allylic alcohol 7 as the only
isomer in much higher yield (84%) compared to that of the direct
elimination reaction of the cyclic sulfate (39%). When the
solvent of one-pot process was replaced with toluene, the yield
of 7 was slightly improved to 88%. Alternatively and more
conveniently, 7 could be obtained in similar yield (87%) by
simultaneous addition of both Bu4NI and DBU to a toluene
solution of cyclic sulfate 6 and refluxing for 2 h. At this stage,
it is of interest to note that diol 5 could be converted to allylic
alcohol 7 even without column chromatographic purification
of cyclic sulfate intermediate 6 in similar overall yield (80%)
(Scheme 1).
With a facile route to the large-scale preparation of the desired
compound 7, efforts were next directed toward the deprotection
steps. The silyl group was removed by treatment with Bu4NF
in THF, affording the known 2-azidosphingosine 3 in 99% yield.
The analytical and spectroscopic data of 3 were in good
agreement with literature data.7,9
Alternatively, when the known diol 9,9a,18 containing an acid-
labile trityl ether protecting group, was employed as a 1,2-
amino-alcohol protected phytosphingosine, the application of
the above sequence also successfully afforded 2-azidosphin-
gosine 3 in high overall yield (Scheme 2). The diol 9 was
converted to a cyclic sulfate, which was submitted directly to
one-pot ring opening/dehydrohalogenation conditions (Bu4NI
and DBU in refluxing toluene) without column chromatography.
Exposure of the resulting reaction mixture to HCl/THF resulted
in simultaneous hydrolysis of the sulfate ester intermediate and
removal of the trityl protecting group to give the 2-azidos-
phingosine 3 in 80% overall yield.
Experimental Section
(2S,4S,5R)-[2-Azido-2-(2,2-dioxo-5-tetradecyl-2λ6-[1,3,2]diox-
athiolan-4-yl)ethoxy]-tert-butyldiphenylsilane (6). To a solution
of diol 5 (1.10 g, 1.88 mmol) in CH2Cl2 (10 mL) were added
triethylamine (786 µL, 5.64 mmol) and thionyl chloride (160 µL,
2.26 mmol) at 0 °C. After 30 min, this reaction mixture was poured
into brine and extracted with EtOAc. The organic layer was dried
over Na2SO4 and concentrated. This crude cyclic sulfite was dried
in vacuo for 3 h and dissolved in CCl4/CH3CN/H2O (12 mL, 1:1:
1). To the resulting solution were added RuCl3‚3H2O (19 mg, 0.09
mmol) and NaIO4 (1.21 g, 5.64 mmol). After this reaction mixture
was stirred at room temperature for 2 h, it was diluted with EtOAc
and washed with saturated NaHSO3 solution. The organic layer
was dried over Na2SO4, concentrated, and purified by column
chromatography on silica gel (hexane/EtOAc, 10:1) to give cyclic
sulfate 6 (1.09 g, 90%) as a colorless oil: [R]25 +53.8 (c 1.0,
D
1
CHCl3); H NMR (CDCl3, 300 MHz) δ 0.90 (t, J ) 6.6 Hz, 3H),
1.11 (s, 9H), 1.29 (s, 22H), 1.47-1.63 (m, 2H), 1.71-1.80 (m,
1H), 1.88-2.00 (m 1H), 3.70 (ddd, J ) 2.4, 5.1, 9.9 Hz, 1H), 3.91
(dd, J ) 5.1, 11.4 Hz, 1H), 4.05 (dd, J ) 2.4, 11.4 Hz, 1H), 4.91-
5.03 (m, 2H), 7.41-7.51 (m, 6H), 7.68-7.72 (m, 4H); 13C NMR
(CDCl3, 75 MHz) δ 14.1, 19.1, 22.6, 25.1, 26.6, 28.0, 28.9, 29.2,
29.3, 29.4, 29.5, 29.59, 29.61, 29.63, 31.9, 59.1, 63.5, 79.8, 86.4,
127.90, 127.92, 130.1, 131.9, 132.1, 135.47, 135.50; IR (CHCl3)
υmax 2108, 1392 (cm-1); HRMS (FAB) calcd for C34H52O5N3SiS
642.3397 ([M-H]-), found 642.3378.
(2S,3R)-(E)-2-Azido-1-(tert-butyldiphenylsilyoxy)octadec-4-en-
3-ol (7). To a solution of cyclic sulfate 6 (534 mg, 0.83 mmol) in
toluene (8 mL) were added Bu4NI (336 mg, 0.91 mmol) and DBU
(187 µL, 1.25 mmol). This reaction mixture was heated to reflux
for 2 h. The reaction was cooled to room temperature, and to it
were added concentrated H2SO4 (14 µL), H2O (17 µL), and THF
(217 µL). The mixture was stirred for 1 h at room temperature and
then diluted with EtOAc. It was washed with saturated aqueous
NaHCO3 solution and brine. The organic layer was dried over Na2-
SO4 and concentrated. The crude product was purified by silica
gel column chromatography (hexane/EtOAc, 10:1) to give 7 (408
mg, 87%) as a colorless oil: [R]25D +2.54 (c 1.0, CHCl3); 1H NMR
(CDCl3, 300 MHz) δ 0.89 (t, J ) 6.9 Hz, 3H), 1.08 (s, 9H), 1.26
(s, 20H), 1.31-1.33 (m, 2H), 1.98-2.05 (m, 2H), 3.51 (td, J )
1.2, 5.1 Hz, 1H), 3.77 (dd, J ) 4.5, 11.1 Hz, 1H), 3.82 (dd, J )
6.6, 11.1 Hz, 1H), 4.23 (app. t, J ) 6.0 Hz, 1H), 5.43 (tdd, J )
1.2, 6.9, 15.3 Hz, 1H), 5.74 (dtd, J ) 0.9, 7.8, 15.3 Hz, 1H), 7.37-
7.48 (m, 6H), 7.67-7.70 (m, 4H); 13C NMR (CDCl3, 75 MHz) δ
14.1, 19.0, 22.6, 26.7, 28.9, 29.1, 29.3, 29.4, 29.5, 29.6, 31.9, 32.2,
A final reduction of the azide to an amino group was achieved
by treatment of 3 with NaBH4 in refluxing 2-propanol19 to give
D-erythro-sphingosine (1) as waxy solid in 87% isolated yield
(Scheme 2). Other literature conditions,6c,20 such as Staudinger
reaction, LiAlH4, and Zn/NH4Cl, gave several products and
(18) (a) Fan, G.-T.; Pan, Y.-s.; Lu, K.-C.; Cheng, Y.-P.; Lin, W.-C.;
Lin, S.; Lin, C.-H.; Wong, C.-H.; Fang, J.-M.; Lin, C.-C. Tetrahedron 2005,
61, 1855-1862. (b) Kratzer, B.; Mayer, T. G.; Schmidt, R. R. Eur. J. Org.
Chem. 1998, 291-298. (c) Morita, M.; Sawa, E.; Yamaji, K.; Sakai, T.;
Natori, T. Biosci., Biotechnol., Biochem. 1996, 60, 288-292.
(19) Kiso, M.; Nakamura, A.; Tomita, Y.; Hasegawa, A. Carbohydr.
Res. 1986, 158, 101-111.
(20) (a) Yadav, J. S.; Vidyanand, D.; Rajagopal, D. Tetrahedron Lett.
1993, 34, 1191-1194. (b) Milne, J. E.; Jarowicki, K.; Kocienski, P. J.;
Alonso, J. Chem. Commun. 2002, 426-427.
(21) Owing to the reported instability of 1, it was also characterized as
the triacetate derivative 10.
(22) (a) Lee, J.-M.; Lim, H.-S.; Chung, S.-K. Tetrahedron: Asymmetry
2002, 13, 343-347. (b) Ohashi, K.; Kosai, S.; Arizuka, M.; Watanabe, T.;
Yamagiwa, Y.; Kamikawa, T. Tetrahedron 1989, 45, 2557-2570 and
references therein.
J. Org. Chem, Vol. 71, No. 22, 2006 8663